GSK shares fell after the U.K. drugmaker said it would stop working on an experimental treatment for chronic cough after mixed results showed limited efficacy in late-stage clinical studies. https://t.co/zvCdQwuxRw ...

Eli Lilly has been selling pills to sick people for 150 years. But now, it wants to push treatments that stop people getting ill in the first place. Will it work? Listen to the latest episode of “Money Talks” to find out https://t.co/8Qmb1Ko5Ja ...

The Inside Story Of The World’s First Cannabis-Based Painkiller https://t.co/BCbxTPQdQW (Photo: Vertanical) https://t.co/xta3Ah90OM ...

In today's daily health, the Food and Drug Administration has approved a new daily pill called Lipfenra that can lower cholesterol levels further than what can be achieved with statins. Those are the widely prescribed medications already on the market. Clinical trials show this new pill can bring levels of what's called bad cholesterol or LDL down to 50 or 60 or even lower.Doctors often recommend an LDL 70 and below for a healthy person. Joining us now is NBC News medical contributor Dr. . Natalie Azar.Good ...

How is Eli Lilly reinventing pharma? On this week’s “Money Talks” we interview David Ricks, the trillion-dollar drugmaker’s CEO https://t.co/WnWWivuUCK ...